Article Details
Retrieved on: 2021-04-27 15:00:00
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Roche's Evrysdi, an oral drug licensed from PTC Therapeutics, posted first-quarter US sales of CHF79m ($86m), a 72% quarter-on-quarter increase in ...
Article found on: www.evaluate.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here